ADTX - Aditxt jumps 10% on signing amendment to extend worldwide licensing agreement granting exclusivity in all fields of use

Aditxt (NASDAQ:ADTX) jumps 10% pre market as it signs an amendment to its February 3, 2020, exclusive license agreement with Stanford University, extending Aditxt’s exclusive right to license the technology deployed in AditxtScore and securing worldwide exclusivity in all fields of use of the licensed technology. The amendment expands AditxtScore’s clinical utility for personalizing the selection of the right treatment for individuals and monitoring their response to the treatment. Recently, the company announced share exchange agreement to acquire AiPharma

For further details see:

Aditxt jumps 10% on signing amendment to extend worldwide licensing agreement, granting exclusivity in all fields of use